Stoller JK - Search Results

1

Hatipoğlu U, Stoller JK. Hatipoğlu U, et al. Among authors: stoller jk. Clin Chest Med. 2016 Sep;37(3):487-504. doi: 10.1016/j.ccm.2016.04.011. Epub 2016 Jun 25. Clin Chest Med. 2016. PMID: 27514595 Review.

2

Alpha 1-antitrypsin deficiency registry.

Stoller JK, Williams GW, Crystal RG. Stoller JK, et al. Chest. 1990 May;97(5):1278. doi: 10.1378/chest.97.5.1278b. Chest. 1990. PMID: 2331946 No abstract available.

3

Physical and social impact of alpha 1-antitrypsin deficiency: results of a survey.

Stoller JK, Smith P, Yang P, Spray J. Stoller JK, et al. Cleve Clin J Med. 1994 Nov-Dec;61(6):461-7. doi: 10.3949/ccjm.61.6.461. Cleve Clin J Med. 1994. PMID: 7828337 Free article.

4

Baseline characteristics of enrollees in the National Heart, Lung and Blood Institute Registry of alpha 1-antitrypsin deficiency. Alpha 1-Antitrypsin Deficiency Registry Study Group.

McElvaney NG, Stoller JK, Buist AS, Prakash UB, Brantly ML, Schluchter MD, Crystal RD. McElvaney NG, et al. Among authors: stoller jk. Chest. 1997 Feb;111(2):394-403. doi: 10.1378/chest.111.2.394. Chest. 1997. PMID: 9041988

5

Quality control of spirometry testing in the registry for patients with severe alpha1-antitrypsin deficiency. alpha1-Antitrypsin Deficiency Registry Study Group.

Stoller JK, Buist AS, Burrows B, Crystal RG, Fallat RJ, McCarthy K, Schluchter MD, Soskel NT, Zhang R. Stoller JK, et al. Chest. 1997 Apr;111(4):899-909. doi: 10.1378/chest.111.4.899. Chest. 1997. PMID: 9106567 Free article.

6

Clinical features and natural history of severe alpha 1-antitrypsin deficiency. Roger S. Mitchell Lecture.

Stoller JK. Stoller JK. Chest. 1997 Jun;111(6 Suppl):123S-128S. doi: 10.1378/chest.111.6_supplement.123s. Chest. 1997. PMID: 9184559 Review. No abstract available.

7

Lung disease due to alpha 1-antitrypsin deficiency.

Wiedemann HP, Stoller JK. Wiedemann HP, et al. Among authors: stoller jk. Curr Opin Pulm Med. 1996 Mar;2(2):155-60. doi: 10.1097/00063198-199603000-00013. Curr Opin Pulm Med. 1996. PMID: 9363132 Review.

8

Feasibility of a clinical trial of augmentation therapy for alpha(1)-antitrypsin deficiency. The Alpha 1-Antitrypsin Deficiency Registry Study Group.

Schluchter MD, Stoller JK, Barker AF, Buist AS, Crystal RG, Donohue JF, Fallat RJ, Turino GM, Vreim CE, Wu MC. Schluchter MD, et al. Among authors: stoller jk. Am J Respir Crit Care Med. 2000 Mar;161(3 Pt 1):796-801. doi: 10.1164/ajrccm.161.3.9906011. Am J Respir Crit Care Med. 2000. PMID: 10712324

9

Formation and current results of a patient-organized registry for alpha(1)-antitrypsin deficiency.

Stoller JK, Brantly M, Fleming LE, Bean JA, Walsh J. Stoller JK, et al. Chest. 2000 Sep;118(3):843-8. doi: 10.1378/chest.118.3.843. Chest. 2000. PMID: 10988213

10

The direct medical costs of alpha(1)-antitrypsin deficiency.

Mullins CD, Huang X, Merchant S, Stoller JK; Alpha One Foundation Research Network Registry Investigators. Mullins CD, et al. Among authors: stoller jk. Chest. 2001 Mar;119(3):745-52. doi: 10.1378/chest.119.3.745. Chest. 2001. PMID: 11243952

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

355 results

Search Page